Articles by GU Oncology Now Editors
Articles from the December 2022 issue of the GU Oncology Now Journal
Articles from the November 2022 issue of the GU Oncology Now Journal
Articles from the October 2022 issue of the GU Oncology Now Journal
Cell-based therapies have shown efficacy in disease settings, but for solid tumors, research has proceeded at a slower pace.
Articles from the September 2022 issue of the GU Oncology Now Journal
Evan Ya-Wen Yu, MD, talks about different types of precision medicine, the future of precision medicine, and more.
Part two of an interview with Russell Szmulewitz, MD on the benefits of PSMA-PET for high-risk and advanced prostate cancer.
Part one of an interview with Russell Szmulewitz, MD on the benefits of PSMA-PET for high-risk and advanced prostate cancer.
Evan Ya-Wen Yu, MD, discusses what precision medicine is, how patients were treated before precision medicine, and more.
Prostate cancer highlights from ASCO 2022 are discussed, including the ENZAMET trial design and TheraP trial data.
Drs. Michael Morris and Akhil Saji discuss the future of PSMA-targeted therapies in advanced prostate cancer.
670 Madison Ave.
Manalapan, NJ 07726